Maria Izco

Logrono, LO 26006, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Corrigendum to: "Oral subchronic exposure to the mycotoxin ochratoxin A induces key pathological features of Parkinson's disease in mice six months after the end of the treatment" [Food Chem. Toxicol. (2021) 152 112164].

Corrigendum to: "Oral subchronic exposure to the mycotoxin ochratoxin A induces key pathological features of Parkinson's disease in mice six months after the end of the treatment" [Food Chem. Toxicol. (2021) 152 112164].

Journal: Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association

Published: August 05, 2026

Development of human targeted extracellular vesicles loaded with shRNA minicircles to prevent parkinsonian pathology.

Development of human targeted extracellular vesicles loaded with shRNA minicircles to prevent parkinsonian pathology.

Journal: Translational neurodegeneration

Published: November 15, 2024

High-Performance Liquid Chromatography-Fluorescence Detection Method for Ochratoxin A Quantification in Small Mice Sample Volumes: Versatile Application across Diverse Matrices Relevant for Neurodegeneration Research.

High-Performance Liquid Chromatography-Fluorescence Detection Method for Ochratoxin A Quantification in Small Mice Sample Volumes: Versatile Application across Diverse Matrices Relevant for Neurodegeneration Research.

Journal: Toxins

Published: April 14, 2024

Gut microbiota produces biofilm-associated amyloids with potential for neurodegeneration.

Gut microbiota produces biofilm-associated amyloids with potential for neurodegeneration.

Journal: Nature communications

Published: November 06, 2023

Targeted Extracellular Vesicle Gene Therapy for Modulating Alpha-Synuclein Expression in Gut and Spinal Cord.

Targeted Extracellular Vesicle Gene Therapy for Modulating Alpha-Synuclein Expression in Gut and Spinal Cord.

Journal: Pharmaceutics

Published: February 24, 2023

Impact of endolysosomal dysfunction upon exosomes in neurodegenerative diseases.

Impact of endolysosomal dysfunction upon exosomes in neurodegenerative diseases.

Journal: Neurobiology of disease

Published: September 30, 2021

Biomonitoring of Mycotoxins in Plasma of Patients with Alzheimer's and Parkinson's Disease.

Biomonitoring of Mycotoxins in Plasma of Patients with Alzheimer's and Parkinson's Disease.

Journal: Toxins

Published: June 02, 2021

siRNA Loaded-Exosomes.

siRNA Loaded-Exosomes.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: April 30, 2021

The Two Faces of Exosomes in Parkinson's Disease: From Pathology to Therapy.

The Two Faces of Exosomes in Parkinson's Disease: From Pathology to Therapy.

Journal: The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry

Published: February 03, 2021

Oral subchronic exposure to the mycotoxin ochratoxin A induces key pathological features of Parkinson's disease in mice six months after the end of the treatment.

Oral subchronic exposure to the mycotoxin ochratoxin A induces key pathological features of Parkinson's disease in mice six months after the end of the treatment.

Journal: Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association

Published: January 22, 2021

Oral Sub-chronic Ochratoxin A Exposure Induces Gut Microbiota Alterations in Mice.

Oral Sub-chronic Ochratoxin A Exposure Induces Gut Microbiota Alterations in Mice.

Journal: Toxins

Published: January 13, 2021

Glial activation precedes alpha-synuclein pathology in a mouse model of Parkinson's disease.

Glial activation precedes alpha-synuclein pathology in a mouse model of Parkinson's disease.

Journal: Neuroscience research

Published: July 28, 2020

Showing 1-12 of 16

Last Updated: 09/26/2026